PAPER Lewczuk P, Popp J, Lelental N, Kölsch H, Maier W, Kornhuber J, Jessen F
SEARCH RESULTS
331007 RESULTS
PAPER Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, Lynch MA
Modest Amyloid Deposition is Associated with Iron Dysregulation, Microglial Activation, and Oxidative Stress.
J Alzheimers Dis. 2012 Jan 1;28(1):147-61. PubMed: 21971404PAPER Baker LD, Bayer-Carter JL, Skinner J, Montine TJ, Cholerton BA, Callaghan M, Leverenz JB, Walter BK, Tsai E, Postupna N, Lampe J, Craft S
High-Intensity Physical Activity Modulates Diet Effects on Cerebrospinal Amyloid-β Levels in Normal Aging and Mild Cognitive Impairment.
J Alzheimers Dis. 2012;28(1):137-46. PubMed: 21971406PAPER Kaneai N, Arai M, Takatsu H, Fukui K, Urano S
Vitamin e inhibits oxidative stress-induced denaturation of nerve terminal proteins involved in neurotransmission.
J Alzheimers Dis. 2012;28(1):183-9. PubMed: 21971407PAPER Sanchez MM, Moghadam S, Naik P, Martin KJ, Salehi A
Hippocampal network alterations in Alzheimer's disease and Down syndrome: from structure to therapy.
J Alzheimers Dis. 2011;26 Suppl 3:29-47. PubMed: 21971449PAPER Fennema-Notestine C, Panizzon MS, Thompson WR, Chen CH, Eyler LT, Fischl B, Franz CE, Grant MD, Jak AJ, Jernigan TL, Lyons MJ, Neale MC, Seidman LJ, Tsuang MT, Xian H, Dale AM, Kremen WS
Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age.
J Alzheimers Dis. 2011;26 Suppl 3:49-60. PubMed: 21971450PAPER Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, Camicioli R, Csernansky JG, de Leon MJ, Detoledo-Morrell L, Killiany RJ, Lehéricy S, Pantel J, Pruessner JC, Soininen H, Watson C, Duchesne S, Jack CR, Frisoni GB
Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol.
J Alzheimers Dis. 2011;26 Suppl 3:61-75. PubMed: 21971451PAPER Tosun D, Schuff N, Shaw LM, Trojanowski JQ, Weiner MW,
Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.
J Alzheimers Dis. 2011;26 Suppl 3:77-90. PubMed: 21971452PAPER Kerchner GA
Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:91-5. PubMed: 21971453PAPER Weih M, Degirmenci U, Kreil S, Suttner G, Schmidt D, Kornhuber J, Lewczuk P, Kuwert T
Nuclear medicine diagnostic techniques in the era of pathophysiology-based CSF biomarkers for Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:97-103. PubMed: 21971454PAPER Furst AJ, Lal RA
Amyloid-β and glucose metabolism in Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:105-16. PubMed: 21971455PAPER Austin BP, Nair VA, Meier TB, Xu G, Rowley HA, Carlsson CM, Johnson SC, Prabhakaran V
Effects of hypoperfusion in Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:123-33. PubMed: 21971457PAPER Jensen JR, Cisek K, Funk KE, Naphade S, Schafer KN, Kuret J
Research towards tau imaging.
J Alzheimers Dis. 2011;26 Suppl 3:147-57. PubMed: 21971459PAPER Shin J, Kepe V, Barrio JR, Small GW
The merits of FDDNP-PET imaging in Alzheimer's disease.
J Alzheimers Dis. 2011;26 Suppl 3:135-45. PubMed: 21971458PAPER Drago V, Babiloni C, Bartrés-Faz D, Caroli A, Bosch B, Hensch T, Didic M, Klafki HW, Pievani M, Jovicich J, Venturi L, Spitzer P, Vecchio F, Schoenknecht P, Wiltfang J, Redolfi A, Forloni G, Blin O, Irving E, Davis C, Hårdemark HG, Frisoni GB
Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage.
J Alzheimers Dis. 2011;26 Suppl 3:159-99. PubMed: 21971460Current Filters
No filters selected